Clinical practice supports what the randomized trials have shown – continuous aspiration of subglottic secretions with the Hi-Lo Evac^® endotracheal tube consistently reduces VAP. With usage exceeding one million patients, more and more hospitals are realizing significant drops in their VAP rates with the Hi-Lo Evac tube, even when other interventions are already in use.

Click below for summaries of published articles by clinicians who have successfully reduced their hospital’s VAP rates with the Hi-Lo Evac tube.

• Garbarini P, Ryland B. Continuous Aspiration of Subglottic Secretions – Impact on Ventilator-Associated Pneumonia in a General Intensive Care Unit. Respiratory Care, 2003;48(11):1062. Abstract of poster presentation at American Association of Respiratory Care Annual Convention.
• Keith DD, Garrett KM, Hicko XG, Echols B, Comeau E. Improved Clinical Outcomes. Journal of Nursing Care Quality.2004;19(4):328-333.

Your VAP improvement story can help other hospitals succeed in their efforts. To share a success story from your institution, click here.